4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-15-043709
CIK 0001516479operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:02 PM ET
Size
7.3 KB
Accession
0001209191-15-043709
Insider Transaction Report
Form 4
BAKER DARRYL S
Chief Financial Officer
Transactions
- Sale
Common Stock
2015-05-18$58.83/sh−4,000$235,320→ 9,377 total - Sale
Common Stock
2015-05-18$59.40/sh−6,000$356,400→ 13,377 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $59.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.25 to $59.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:02 PM ET
- Size
- 7.3 KB